FOXK2 amplification promotes breast cancer development and chemoresistance
Yang Yu(Children's National), Hong Zhang(Memorial Sloan Kettering Cancer Center)
Cited by 11
Related Papers
A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment
|Nature Medicine|2018|453
METTL3 Inhibition Suppresses Cell Growth and Survival in Colorectal Cancer via ASNS Downregulation
|Journal of Cancer|2024|13
<i>FOXK2</i> amplification and overexpression promotes breast cancer development and chemoresistance
|bioRxiv (Cold Spring Harbor Laboratory)|2023|1